Constellation Brands (STZ) β†’ Stock, financial statements
Advertising

Constellation Brands

240.44 USD +1.66 (+0.74%)
Nov 19 πŸ‡ΊπŸ‡Έ NYSE STZ
Dividends
Favorites
  • STZ Ticker
  • πŸ‡ΊπŸ‡Έ NYSE Exchange
  • 9,600 Employees
5 rated
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon

Financial statements β€” Constellation Brands

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
21 ← 16 2021 2020 2019 2018 2017 2016
Total Revenue
9.4B 9.1B 8.9B 8.3B 8.1B 7.2B
Cost Of Revenue
4.1B 4.2B 4B 3.8B 3.8B 3.6B
Gross Profit
5.2B 4.9B 4.8B 4.6B 4.3B 3.6B
Research and Development
0 0 0 0 0 0
Selling General and Admin
1.7B 1.6B 1.7B 1.5B 1.4B 1.2B
Operating Expense
6.6B 6.6B 6.5B 6B 5.9B 5.5B
Operating Income
2.8B 2.5B 2.4B 2.3B 2.1B 1.8B
Other Income Expense Net
0 0 0 0 0 0
EBIT
3B -140M 4.5B 2.8B 2.2B 1.8B
Interest Income
390M 430M 370M 330M 330M 310M
Pretax Income
2.5B -950M 4.1B 2.3B 2.1B 1.5B
Income Tax
510M -970M 690M 12M 550M 440M
Minority Interest
34M 33M 23M 12M 4.1M 5.7M
Net Income
2B -12M 3.4B 2.3B 1.5B 1.1B
Net Income Basic
2B -12M 3.4B 2.3B 1.5B 1.1B
21 ← 16 2021 2020 2019 2018 2017 2016
Current cash
460M 81M 94M 90M 180M 83M
Short term investments
200M 190M 190M 190M 260M 190M
Receivables
1.1B 1.2B 1.3B 1.1B 840M 860M
Inventory
1.3B 1.4B 2.1B 2.1B 2B 1.9B
Other current assets
200M 190M 190M 190M 260M 190M
Current assets
3B 3.5B 3.7B 3.5B 3.2B 3B
Long term investments
24B 24B 26B 17B 15B 14B
Property plant equipment
5.8B 5.3B 5.3B 4.8B 3.9B 3.3B
Goodwill
7.8B 7.8B 8.1B 8.1B 7.9B 7.1B
Intangible assets
2.7B 2.7B 3.2B 3.3B 3.4B 3.4B
Other assets
610M 130M 110M 110M 140M 110M
Total assets
27B 27B 29B 21B 19B 17B
Accounts payable
460M 560M 620M 590M 560M 430M
Current long term debt
29M 970M 1.9B 770M 1.5B 1.3B
Other current liabilities
780M 780M 690M 580M 620M 580M
Total current liabilities
1.3B 2.3B 3.2B 1.9B 2.7B 2.3B
Long term debt
10B 11B 12B 9.4B 7.7B 6.8B
Other liabilities
450M 460M 0 400M 170M 160M
Minority Interest
330M 340M 290M 17M -6.4M 130M
Total Liabilities
14B 15B 17B 12B 12B 10B
Common stock
190M 190M 190M 190M 200M 190M
Retained earning
15B 14B 14B 9.2B 7.3B 6.1B
Treasury stock
-2.8B -2.8B -2.8B -3.8B -2.8B -1.7B
Capital surplus
β€’ β€’ β€’ β€’ β€’ β€’
Shareholder equity
14B 12B 13B 8B 6.9B 6.6B
Net tangible assets
3.1B 1.7B 1.3B -3.3B -4.4B -4B
21 ← 16 2021 2020 2019 2018 2017 2016
Net Income
2B -12M 3.4B 2.3B 1.5B 1.1B
Depreciation
290M 330M 340M 300M 290M 220M
Changes in receivables
-130M -53M 160M 270M -20M 170M
Changes in inventories
-83M -760M 46M 130M 100M 24M
Cash change
380M -12M 3.3M -87M 94M -27M
Cash flow
2.8B 2.6B 2.2B 1.9B 1.7B 1.4B
Capital expenditures
-860M -730M -890M -1.1B -910M -890M
Investments
β€’ β€’ β€’ β€’ β€’ β€’
Investing activity other
β€’ β€’ β€’ β€’ β€’ β€’
Total investing cash flows
-88M -530M -4.8B -1.4B -1.5B -2.2B
Dividends paid
β€’ β€’ β€’ β€’ β€’ β€’
Net borrowings
9.8B 12B 13B 9.9B 8.8B 7.8B
Other financing cash flows
β€’ β€’ β€’ β€’ β€’ β€’
Cash flow financing
-2.3B -2B 2.6B -600M -130M 780M
Exchange rate effect
β€’ β€’ β€’ β€’ β€’ β€’

American diversified manufacturer and seller of beer, wine and spirits. It is the largest importer of beer by sales, occupying a third share of the US market. 64.1% of sales are accounted for beer, 31.2% - for wine, the rest is determined by the sale of whiskey, vodka and rum. The company imports its products to Canada, Mexico, Italy and New Zealand.

The range of alcoholic beverages includes about 100 brands. Wine brands include table, sparkling and dessert wines of various price categories. The company sells a number of brands in the import and craft beer categories, including Corona Extra, Corona Light, Modelo Especial, and others.

Through a partnership with the canadian company Canopy Growth, the corporation invests part of its funds in cannabis (medical marijuana). It owns 40 % of the manufacturer's profit, although this production has not yet brought in large revenues. The corporation became the first Fortune 500 company to acquire a minority stake in this type of business.